FDA approves Bayer … [Read more...]
PSA Screening – Where are we now?
by Jan Manarite, VP of Advocacy & Education Lonnie Silva’s story (Click here) of having to ask for a PSA blood test for almost 10 years, just to get a baseline and screen for prostate cancer is frustrating to read. Even more frustrating is that his first PSA came in at 22.1 after being … [Read more...]
My Prostate Cancer Story: Avid Reader Becomes Advocate
By Lonnie Silva As I approached my mid-50s, I enjoyed reading well respected American publications. As an avid reader, I was never one for subscribing to rag sheets or the infamous tabloids. One subject on my reading list was prostate cancer. Through my research, I discovered a new blood test … [Read more...]
New PET Scan Approved for Prostate Cancer – for PSA Recurrence After Treatment
On May 27, 2016, the FDA approved a new PET Scan tracer (injection) for prostate cancer patients with “suspected prostate cancer recurrence based on elevated prostate specific antigen (PSA) levels following prior treatment.” (1) There are several names for this new PET imaging agent, but they … [Read more...]
Focal Therapy – Brief Overview and Focal Cryo Experience at PIOA
Duke K. Bahn, MD • Prostate Institute of America (www.PIOA.ORG) • Ventura, California (805) 585-3082 or (888) 234-0004 INTRODUCTION: The progression of clinically localized prostate cancer is usually slower than other cancers, and has confounded the development of a … [Read more...]
Some Current Trials – In the Field of Biomarkers
Clinical trials are constantly changing. But to offer our readers some current options that might be worth researching, here is what I found for clinical trials using BRCA testing, or AR-V7 testing – both of which are mentioned in Dr Eshaghian’s article here. CURRENT TRIALS IN … [Read more...]
On the Horizon-Individualized Biomarker Driven Therapy for CRPC
By Shahrooz Eshaghian, MD FACP • Compassionate Oncology Medical Group Clinical Instructor UCLA School of Medicine • Attending Physician, Division of Hematology & Oncology at Cedars Sinai Medical Center eshaghian@compassionateoncology.org The past decade has brought many advances … [Read more...]
Adding Prednisone to Zytiga – More Side Effects?
I have heard a few prostate cancer patients comment that they are worried about taking Zytiga (abiraterone) because they are concerned about the side effects of the 5 mg prednisone ( 2 x day) which is prescribed with the Zytiga. People who have been on prednisone for other reasons (gout, arthritis, … [Read more...]
AR-V7 Blood Test now Available – for mCRPC Patients
The AR-V7 blood test may help patients and doctors make decisions on treatment choices when prostate cancer patients are metastatic, and castrate resistant, or mCRPC. The term AR-V7 stands for androgen-receptor splice variant 7. This blood test recently became available to the public through Johns … [Read more...]
Dr Fred Lee, 1930 – 2016
PAACT mourns the loss of Dr Fred Lee, the Father of color Doppler ultrasound for prostate, and a pioneer in cryotherapy in the USA. He was a true advocate at heart, and helped hundreds of patients in his clinic in Rochester, Michigan. Dr Lee often joked that his close friend Dr Duke … [Read more...]
- 1
- 2
- 3
- …
- 38
- Next Page »